Phase 2 study of FLAGM (Fludarabine+high-dose ara-C+G-CSF+Mitoxantrone) for relapsed, refractory acute myeloid leukemia (AML) : a report from the Japan Adult Leukemia Study Group (JALSG)

収録刊行物

• Blood

  Blood 114 437-, 2009